Zaklady Farmaceutyczne Polpharma S.A.

4 trials Commercial sponsor

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

0 Recruiting

4 Completed trials

2 Countries active

1 Unique IMPs

100% Results reported

Phase IV

Phase I (Other)

Other

Phase IV: 1 Phase I (Other): 1 Other: 2

100%

4 of 4 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Erectile dysfunction 1 Flatulence 1 Essential hypertension 1

Top IMPs

SILDENAFIL CITRATE 1

All trials

4 total

Randomized, open-label, laboratory-blinded, balanced, single dose, 3-treatment, 6-sequence, 3-period crossover comparative bioavailability s… Ended

2026-525256-29-00 Phase I (Other) 1 country
Multicenter study on patient’s ability to independently and safely use of Sildenafil 100 mg for erectile dysfunction. Ended

2025-522923-81-00 Phase IV 1 country SILDENAFIL CITRATE
An open label, randomized, single dose, two-sequence, two-treatment, four-period, fully replicate, cross-over pharmacokinetic study comparin… Ended

2024-516942-21-00 1 country
A single-dose, randomized, two-period, two-sequence, crossover comparative bioavailability study on formulations containing ramipril, amlodi… Ended

2024-514456-32-00 1 country

Showing 1–4 of 4 trials

← All sponsors A–Z